RabAvert
STN: BL 103334
Proper Name: Rabies Vaccine
Tradename: RabAvert
Manufacturer: Bavarian Nordic A/S
Indication:
- For pre-exposure vaccination, in both primary series and booster dose, and for post-exposure prophylaxis against rabies in all age groups.
Product Information
Supporting Documents
- May 9, 2024 Approval Letter - RabAvert
- October 3, 2023 Approval Letter - RabAvert
- August 3, 2018 Approval Letter - RabAvert
- Supporting Documents older than three years - RabAvert - Rabies Vaccine